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Ambient air pollution is a contributing factor to respiratory morbidity and mortality and asth-
matics are a particularly vulnerable population. The aim of the study was to investigate
whether acute exposure to traffic related air pollution in a road tunnel would increase bron-
chial responsiveness in mild asthmatics, and if this would be accompanied by increased
measures of inflammatory markers in the airways assessed by nasal lavage (NAL) and induced
sputum.
Fourteen mild asthmatics (7 treated with inhaled corticosteroids) were exposed for 2 h in
a road tunnel and a control environment, respectively, separated by at least 3 weeks. Symp-
toms and peak expiratory flow (PEF) were recorded. Seven hours following exposure
sessions, subjects underwent measurements of fraction of exhaled nitric oxide (FENO),
spirometry, and a bronchial provocation test. NAL, induced sputum and blood samples were
collected.
The median PM2.5 and PM10 levels during the exposure occasions in the road tunnel were 80
(range 41e93) mg/m3 and 183 (72e213) mg/m3 respectively. Irritative symptoms from the
airways increased and PEF decreased after road tunnel exposure. Increased levels of IL-
10, IL-12 and TNF-a were observed in NAL fluid from subjects without ongoing inhaled corti-
costeroid treatment. Forced expiratory volume in 1 s (FEV1) and the degree of bronchial
responsiveness in asthmatics did not change significantly after tunnel exposure.524 877 12; fax: þ46 8 33 43 33.
@ki.se (B.-M. Larsson).
0 Elsevier Ltd. All rights reserved.
Airway effects in asthmatics after air pollution exposure 1913We conclude that asthmatics exhibit increased symptoms, decreased PEF and signs of
inflammatory response in the upper airways, after a 2 h road tunnel exposure. Our findings
may further emphasize asthmatics as a vulnerable group to common air pollutants.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
It is by now well established that exposure to ambient air
pollution cause adverse health effects in the population,
with focus on cardiac and pulmonary outcome.1 Traffic is
a major contributor to air pollution in the city environment,
and traffic related exposure has been shown to cause acute
inflammatory effects in humans, both in experimental
chamber studies using diesel exhaust2 as well as in exposure
studies in a “real-life” environment performed in a road
tunnel.3 Asthmatics are especially susceptible to this kind
of exposure and increased symptoms and emergency room
visits are reported among asthmatics in connection with
increased air pollution levels.4 One of the key features in
asthma is increased bronchial responsiveness5 which has
been observed in subjects with stable asthma 24 h following
a 1 h long exposure to diesel exhaust fumes in an experi-
mental chamber.6 This was also accompanied by increased
airway resistance and by increased concentration of IL-6 in
induced sputum. Increased hyperresponsiveness to inhaled
allergens has been observed in asthmatic subjects after
a 30 min exposure session in a road tunnel.7 Additionally,
decreased lung function parameters together with signs of
neutrophilic inflammation, have been observed in asth-
matics after a 2 h long exposure to traffic related air
pollution, by walking along Oxford Street in London.8
The aim of the present study was therefore to investi-
gate if an acute exposure to traffic related air pollution in
a road tunnel would increase bronchial responsiveness in
mild asthmatics, in a similar fashion as observed in the
experimental chamber studies using diesel exhaust fumes.
A secondary aim was to see if this also would be accom-
panied by inflammatory reactions in the upper and lower
airways assessed by nasal lavage and induced sputum.
Subjects and methods
Subjects
Fourteen non-smoking volunteers (9 females, 5 males) with
a mean age of 31 (range 18e55) years were recruited to the
study by advertising at different universities in Stockholm. All
were diagnosed as mild asthmatics and 11 had an allergy to
mite, dander, pollen and/or animal. All of these had a positive
Phadiatop (Phadiatop, Pharmacia-Upjohn, Uppsala,
Sweden), and they also had a positive radioallergosorbent test
(RAST, Pharmacia-Upjohn)(Table 1). The volunteers under-
went a physical examination including chest radiograph, lung
functionmeasurements, andblood routineexamination.Chest
X-ray and lung function tests werewithin the normal range. All
subjects but one were hyperresponsive to methacholine
defined as20% fall in forced expiratory volume in 1 s (FEV1).
Seven out of fourteen subjects were on a regular medication
with inhaled corticosteroids. Five of these also used long-acting b2-agonist treatment. Short-acting b2-agonist was used
on demand. Other anti-inflammatory drugs than inhaled
corticosteroidswere not permitted during the study. The study
was performedout of pollen season andairway infectionswere
not allowed within six weeks before or during exposures.
All participants gave their informed consent and the
local ethics committee at the Karolinska Institutet
approved the study.
Study design
The exposure sessions (control and road tunnel, respec-
tively) took place between 7:00 and 9:00 in the morning,
and were performed in a randomized order separated by at
least 3 weeks. Seven hours after the exposure, the subjects
underwent measurement of fraction of exhaled nitric oxide
(FENO) and spirometry, blood sampling, a bronchial prov-
ocation test, nasal lavage and induced sputum. The whole
examination procedure took approximately 90e120 min.
Symptoms and peak expiratory flow (PEF) was recorded
repeatedly (see below for details).
Exposure settings
The road tunnel exposure was performed during two
morning rush hours (7:00e9:00 am) in a road tunnel in the
central part of Stockholm (So¨derledstunneln). The total
length of the tunnel is almost 1500 m and the traffic
intensity is approximately 120,000 vehicles/day.
The exposure took place in a small room (approximately
6 m2) located between the two tunnels, approximately
50e100 m from the tunnel exit. The room has doors on two
opposite sides that were opened to the adjacent traffic lanes
during the exposure sessions. During both tunnel and control
exposure sessions the subjects alternated 15min intervals of
moderate exercise on a bicycle ergometer with 15 min of
rest. The level of exercise was adjusted so that each subject
achieved a ventilation rate of 20 L/min andm2 body surface.
The control exposure, representing a clean air exposure,
took place in a hospital laboratory and was performed at
the same time of day as the road tunnel exposure.
Exposure measurements
Sampling of particles with a 50% cut-off aerodynamic diam-
eter of 2.5 and 10 mm, respectively (PM2.5 and PM10), was
performed using Harvard impactors (Air Diagnostics and
Engineering Inc., Maine, USA) at a flow rate of 10 L/min. The
impactors were equipped with 37 mm teflon filters (Air Diag-
nostics and Engineering Inc.) with a pore size of 2 mm. Gravi-
metric analysis were performed after 24 h of conditioning
using a Mettler Toledo MT5 scale (Mettler, Greisensee,
Switzerland). The concentrations of airborne ultrafine parti-
cles (aerodynamic diameter 14e100 nm) were determined
Table 1 Patient characteristics and individual values of lung function and airway sensitivity to methacholine (PD20) at
baseline.
Subject
no
Age Sex Asthma maintenance
medication ()
Phadiatop RAST (scale 1e6) FEV1% FVC% VC% PD20
(mg)
1 26 F 0 1 Birch:3, cat:3,
horse:1, dog:1
117 115 116 530
2 37 M 0 1 Cat:2 105 110 110 558
3 31 F 0 1 Cat:3, horse:3, dog:3,
timothy:3, birch:2
102 104 105 104
4 55 M 0 1 Cat:3, horse:3, dog:2,
timothy:3, mugwort:1
81 100 100 608
5 24 F 0 1 Cat:3, horse:4, dog:5,
birch:6, timothy:4,
mugwort:3, dust mite:1
85 83 84 333
6 45 F 0 1 Timothy:3, birch:3 100 114 122 259
7 19 F 0 0 107 99 91 542
8 19 M Budesonide/Formoterol 1 Dust mite:3 94 98 102 <14,2
9 42 F Fluticasone 1 Birch:3 104 117 117 279
10 43 F Budesonide/Formoterol 0 86 102 102 25
11 24 F Budesonide/Formoterol 0 119 115 119 894
12 22 M Budesonide/Formoterol 1 Dust mite:3 118 107 100 6521
13 18 F Fluticasone/Salmeterol 1 Birch:6, timothy:3,
mugwort:3, dog:2, dust mite:2
109 112 104 27
14 29 M Budesonide/Formoterol 1 Cat:3, horse:2, dog:2, timothy:2 113 114 110 120
F Z female, M Z male, FEV1 Z forced expiratory volume in 1 s, FVC Z forced vital capacity, VC Z vital capacity.
PD20 Z airway sensitivity to methacholine measured as dose provoking a 20% fall in FEV1.
1914 B.-M. Larsson et al.using a scanning mobility particle sizer (SMPS) system, elec-
trostatic classifier model 3071 (TSI, Shoreview, MN, USA) in
combinationwith a condensationparticle counter,model CPC
3010 (TSI). The total number of airborne particles in the range
between 20 and 1000 nm in aerodynamic diameter were
monitored with a P-Trak particle counter (TSI). Nitric oxides
levels were monitored during the exposure using a chemilu-
minescent instrument (AC 31M, Environnement, France).
Carbon monoxide levels were measured using an electro-
chemical sensor (Dra¨ger Pac III, Dra¨ger, Germany).
Symptoms
Symptoms from eyes, upper and lower airways were recor-
ded immediately before and every 20 min throughout the
exposure. The intensity was graded from 0 to 10, where
0 corresponded to no symptoms and 10 to severe symptoms,
according to a modified Visual Analogue Scale (VAS). The
average rating obtained during the road tunnel exposure was
compared to the average rating during the control exposure.
Exhaled nitric oxide
Exhaled NO was determined by single-breath exhalation
using a NIOXMINO hand-held analyzer (Aerocrine AB,
Solna, Sweden) at the airflow of 50 mL/s.
Lung function and bronchial hyperresponsiveness
(BHR)
Lung function was measured including parameters for vital
capacity (VC), forced vital capacity (FVC) and forcedexpiratory volume during the first second (FEV1), using
a spirometer (Jaeger Masterscope, CareFusion GmbH,
Hoechberg, Germany). Measurements of peak expiratory
flow (PEF) were performed every hour during the exposure
and approximately every second hour until the last post-
exposure measurements were performed in the evening
using an electronic peak flow meter (PiKo-1, nSpireHealth,
Longmont, CO, USA).
Bronchial responsiveness was assessed by a methacholine
challenge. After a baseline FEV1 registration, the subject
inhaled diluent followed by inhalation of increasing doses of
methacholine, starting at a dose of 14,2 mg, with doubling
doses up to an accumulated dose of 7256 mg. The results are
expressed as the cumulative dose causing a20% decrease in
FEV1 (PD20FEV1) compared to the baseline FEV1. Subjects
who had not attained a 20% decrease in FEV1 when the
maximum cumulative dose (7256 mg) was reached, were
assigned a value (10,000 mg) for the statistical analysis.
Peripheral blood
A cell differential count was performed using an auto-
analyser (Advia 120 Hematology System, Siemens Health-
care Diagnostics, Deerfield, IL, USA).
Nasal lavage
Nasal lavage (NAL) was performed using a procedure
described by Bascom and Pipkorn, with minor modifica-
tion.9,10 Briefly, 5 ml sterile 0.9% NaCl was instilled into one
nostril using a needle-less syringe. After 10 s the fluid was
expelled into a plastic cup. The procedure was repeated in
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cell concentration was counted in a Bu¨rker chamber.
Cytospin prepared slides were stained with May-Gru¨nwald
Giemsa and cells were counted for cell differentials. Less
than 100 cells (n Z 5) were considered as too few cells to
make an accurate differential count. The supernatant was
frozen and stored for mediator analyses.
Sputum induction and sputum processing
All subjects were pre-treated with 200 mg inhaled salbuta-
mol (Ventoline; GlaxoSmithKline AB, Mo¨lndal, Sweden) in
order to avoid extreme airway constriction. Sputum was
induced by inhalation of a hypertonic saline solution at
intervals of 7 min with increasing doses (3, 4 and 5%), and
FEV1 was measured before and after each inhalation. The
saline solution was nebulized using an ultrasonic nebulizer
(DeVilbiss Ultraned 2000; DeVilbiss, Somerset, PA, USA)
with an output of 3 mL min1. After each inhalation the
subjects were encouraged to rinse their mouth with water
and blow their nose before they by deep coughing produced
sputum into a sterile plastic cup, kept on ice. The sputum
samples were poured into petri dishes and macroscopically
examined. Sputum plugs were selected using a forceps and
transferred to a polypropylene test tube with 0.1% dio-
thiothreitol (DTT, Sigma Aldrich Co, St Louis, MO, USA) in
PBS (phosphate-buffered saline) at a volume equal to four
times the selected sputum plugs. The test tubes were
rocked for 15 min. After that an equal volume of PBS was
added and the samples were rocked for another 5 min.
Thereafter the samples were filtered through a 48-mm nylon
filter into another 10 ml test tube and centrifuged for
10 min at 300g at 4 C. The supernatant was centrifuged
once again in a new tube for 10 min at 1000g at 4 C and
finally the supernatant was stored in Eppendorf tubes at
70 C for later analysis. The remaining cell pellet was
resuspended in 1000 ml PBS and adjusted to
0.5  106 cell mL1. Total cell counts and viability were
determined using trypan blue and a Bu¨rker chamber.
Cytospins were prepared using aliquots of cell suspensions
equivalent to 60,000 cells per slide. The material was
centrifuged for 3 min at 22.4g at 4 C in a cytocentrifuge
(Cytospin 2; Shandon, Runcorn, UK), and stained in May-
Gru¨nwald Giemsa for cell differential counts. The
percentages of squamous cells were determined, but not
included in the differential count. Cytospins containing
<80% of squamous cells were considered adequate.11
Inflammatory mediators in nasal lavage and sputum
samples
The concentration of the cytokines interleukin-1b (IL-1b),
IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, interferon-g (IFN-
g), tumor necrosis factor-a (TNF-a), were analysed by flow
cytometry (FACSCalibur, Becton Dickinson) using CBA
(Cytometric Bead Array) technique (Becton Dickinson).
Statistical analysis
Statistical analysis was carried out with SPSS version 15.0
(SPSS, Inc., Chicago, IL, USA). To analyse the response todifferent exposures, the Wilcoxon’s non-parametric rank
sum test for comparisons within the same individuals was
used. P-values from two-sided tests were considered
significant if less than 0.05. Comparison of pre- and post-
exposure lung function data were performed by Students
t-test. The Pearson correlation test was used in order to
determine correlation between exposure parameters and
airway effects.
Results
Road tunnel exposure
The median PM2.5 and PM10 levels during the exposure
occasions in the road tunnel throughout the morning rush
hour were 80 (range 41e93) mg/m3 and 183 (72e213) mg/m3
respectively. The median NO respectively NO2 levels were
711 (274e1317) mg/m3 and 265 (112e579) mg/m3 and the
median CO level was 3.2 (1.4e5.9) mg/m3. The median
number concentration of ambient airborne particles with
an aerodynamic diameter between 20 and 1000 nm was 2.3
(range 2.1e3.1)105/ml measured by the P-Trak instru-
ment. The median of total number concentration of ultra-
fine airborne particles defined as particles less than 100 nm
in diameter, was 1.3 (range 0.8e1.7)105/ml.
Symptoms
Ratings regarding symptoms from the upper and lower
airways increased significantly during the 2 h exposure. In
subjects without ongoing treatment with inhaled corti-
costeroids (ICS) symptoms from the upper airways
increased from 0 (0e0) to 1,0 (0.7e2.3) (p < 0.05), and
symptoms from the lower airways from 0 (0e0) at control
exposure to 1.0 (0.3e2.1) at road tunnel exposure
(p < 0.05). The corresponding values for subjects with
ongoing treatment were 0 (0e1.0) to 1.7 (0.7e2.6)
(p < 0.05) for the upper airways, and for symptoms from
the lower airways the ratings increased from 0.6 (0e1.0)
at control exposure to 2.1 (1.9e3.6) at road tunnel
exposure (p < 0.05).
There were no correlation between increase in airway
symptoms and any of the exposure parameters measured.
Fraction of exhaled nitric oxide (FENO)
The FENO measured 7 h after exposure was not affected by
the road tunnel exposure in neither the untreated nor the
subjects treated with ICS (Table 2).
Lung function and bronchial hyperresponsiveness
The exposure in the road tunnel did not induce a significant
decrease in any of the lung function parameters measured
by a spirometer (FEV1, VC, FVC) at 7 h after exposures. The
results were not affected by splitting the material in
treated and non-treated subjects.
Peak expiratory flow (PEF) measurements performed
during the exposure session in the road tunnel and during
the consecutive hours until the last post-exposure
Table 2 Fraction of exhaled nitric oxide (FENO) measured after exposure (road tunnel and control setting). Data presented as
median (25e75th percentiles). NS Z not statistically significant.
Control (ppb) Road tunnel (ppb) P value
No steroid treatment (n Z 7) 33 (15e57) 29 (13e39) NS
Steroid treatment (n Z 7) 16 (12e23) 14 (12e26) NS
Figure 1 Changes in PEF under and after road tunnel expo-
sure. Unfilled symbols represent values obtained under control
exposure day and filled symbols represent PEF values from the
road tunnel exposure day. There is a significant decrease in
average PEF values when comparing control day versus road
tunnel (P < 0.01 under exposure and P < 0.05 after exposure),
only for subjects without ongoing treatment with inhaled
corticosteroids (ICS). A similar tendency, however not signifi-
cant, was found for ICS treated subjects. Data presented as
mean values and 95% confidence interval. No ICS; n Z 7, ICS
treated; n Z 6.
1916 B.-M. Larsson et al.measurement, were aggregated into two time intervals
before analysis. One average value represent PEF
measurements recorded during exposure session and one
average value represent all measurements performed
during the consecutive hours following exposure. Ana-
lysing all subjects together, a decrease was demonstrated
in PEF during exposure in the road tunnel (p < 0.01), as
well as during the hours following the exposure (p < 0.05)
in comparison with PEF values during the control day.
When splitting the material into treated and untreated
subjects, respectively, the statistical significance
remained only for untreated subjects (p < 0.01 and
p < 0.05, respectively, see Fig. 1). Results from one indi-
vidual in the group treated with ICS was not obtained due
to technical problems.
Bronchial responsiveness increased after road tunnel
exposure compared to control exposure but there was no
statistically significant difference (Table 3). When the
patients were divided into steroid versus non-steroid
treated, no significant difference in PD20 was observed.
Peripheral blood
The total leukocyte cell concentration in blood after
control and road tunnel exposure, respectively, did not
differ significantly (data not shown). No difference in
cellular composition regarding monocytes, lymphocytes
and neutrophilic, basophilic and eosinophilic granulocytes
could be detected when comparing results after control
and road tunnel exposure. This was also consistent after
subdividing the material regarding treatment with steroids
or not.
Nasal lavage
No changes in total cell concentrations or in cellular
differential counts were observed due to road tunnel
exposure (data not shown). This was also consistent after
subdividing the material regarding treatment with steroids
or not.
Induced sputum
Due to individual difficulties in producing adequate sputum
samples, results from both exposure occasions were only
obtained from 6 out of 14 subjects. The cell concentration
in sputum samples was 2168 (1085e5051) (median
25the75th percentiles) cells/mg after control exposure and
2954 (769e3713) cells/mg after road tunnel exposure. The
difference was not statistically significant. Since samples
were obtained from only 2 untreated subjects and
4 subjects with ongoing treatment, respectively, we chose
not to present data in subgroups.Soluble components in nasal lavage
Analysis of cytokines in nasal lavage fluid were per-
formed in the subjects without an ongoing treatment
with inhaled corticosteroids (n Z 7). A statistically
significant increased NAL concentration of IL-10, TNF-
a and IL-12p70 was detected after the road tunnel
exposure compared to values obtained after the corre-
sponding control exposure (p < 0.05 for all cytokines,
Table 4). In two subjects, values from both control day
and road tunnel exposure day were below detection
limit. In one of the remaining 5 subjects, the values
obtained after control exposure were below detection
limit. In order to perform statistical analysis, this subject
was assigned a value (0.001) which was below the
present detection limit.
No changes due to the road tunnel exposure were
observed regarding the levels of IL-1B, IL-6 and IL-8.
Table 3 Bronchial responsiveness measured by methacholine provocation after exposure (road tunnel and control setting) and
presented as dose needed to provoke a 20% decline in pre-exposure FEV1. Data presented as median (25e75th percentiles).
PD20 control (mg) PD20 road tunnel (mg) P value
All subjects (n Z 14) 577 (179e910) 326 (119e763) p Z 0.35
No steroid treatment (n Z 7) 542 (196e686) 162 (128e674) p Z 0.34
Steroid treatment (n Z 7) 730 (85e1296) 440 (44e1029) p Z 0.60
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measured as PM2.5 and increase in IL-10 concentration
(r Z 0.89, p < 0.05).Discussion
Acute effects in the airways following a 2 h long exposure to
ambient air pollution in a road tunnel were examined in
14 subjects diagnosed with mild asthma. Repeated
measurements of PEF during the exposure days, demon-
strated lower mean values following the road tunnel
exposure than after the control exposure, mainly in
subjects without treatment with inhaled corticosteroids
(ICS). Additionally, reports of irritative symptoms from the
airways increased during road tunnel exposure compared to
the control situation. Bronchial reactivity was not signifi-
cantly different between the two exposure situations.
Minor signs of inflammatory response were detected in
nasal lavage. However, no systemic effects were observed
in blood samples, and lung function, measured as FVC, VC
and FEV1, were unaltered by the exposure.
In a previous study3 using the identical exposure
settings, evidence of an inflammatory response in the lower
airways of healthy subjects was found measured as
increased concentrations of lymphocytes and alveolar
macrophages in bronchoalveolar lavage (BAL) fluid. The
exposure levels in the present study were in the same order
as what we measured in the earlier study. PM10 levels
ranging from 14 to 73 mg/m3 has been measured in
19 European cities (including Stockholm).12 The lack of
inflammatory response in the present study could possibly
be explained by different clinical parameters being ana-
lysed in the present study or by technical difficulties.
In studies by Barck et al., the priming effect of NO2
exposure on a subsequent allergen exposure was exam-
ined in allergic subjects. The NO2 exposure enhanced the
allergic response demonstrated by increased percentage
of neutrophils in BAL fluid, although no inflammatoryTable 4 IL-10, TNF-a and IL-12p70 levels (pg/ml) in nasal lavage
corticosteroids (nZ 7). Results are based on data from 5 individu
detection limit for two subjects (subject nr 1 and 4).
Subject IL-10 Control IL-10 Road tunnel TNF-a C
2 0.30 2.30 0.26
3 0.90 1.10 0.71
5 0.40 1.90 0.32
6 2.10 4.50 1.57
7 0.001 1.17 0.001
Median (pg/ml) 0.40 1.90 0.32
25e75th percentiles 0.15e1.50 1.13e3.40 0.13e1.1effects were detected in NAL fluid nor on symptoms or
lung function.13,14 Measurements were performed at
similar time intervals in the two studies. The upper airway
region may thus not be as reactive as the lower airways,
and higher exposure levels might be required to induce an
inflammatory response. An alternative explanation is that
our present study made use of testing methods that were
associated with more missing data compared to studies
focusing on lower airways.3 This was mainly due to
inability of several of the asthmatic subjects to produce
sufficient material for analyses following induced sputum
inductions.
In the present study we were unable to demonstrate
any change in bronchial responsiveness. Seven out of
14 subjects in our study were on regular treatment with
ICS which is known to influence the bronchial respon-
siveness. We performed a subgroup-analysis on the
material but there were no statistically significant
differences when comparing subjects with or without ICS
treatment. However, the small sample weakens the power
of the analyses. A study performed in London investigated
health effects in mild asthmatics after exposure for 2 h to
diesel traffic related ambient air pollution at Oxford
Street.8 Sixty subjects with asthma were recruited; more
than half of them (62%) were treated with ICS. The
participants had a significant larger reduction in lung
function parameters (FEV1, FVC) as well increased
inflammatory response measures as increased concentra-
tion of sputum myeloperoxidase and acidification of
exhaled breath condensate after exposure to diesel traffic
related air pollution at Oxford Street. Effects on lower
airways were detected in spite of ongoing corticosteroid
treatment.
Additionally, an experimental chamber study using pure
diesel exhaust exposure have shown increased bronchial
responsiveness in asthmatic subjects, all on steroid treat-
ment, following a 1 h long exposure at a PM10 level of
300 mg/m3.6 The exposure level in that study was almost
twice as high as the level measured in our road tunnel studyfluid measured in a subgroup without ongoing treatment with
als, since both control and road tunnel values were below the
ontrol TNF-a Road tunnel IL-12 Control IL-12 Road tunnel
4.38 0.21 1.34
0.78 0.77 1.8
1.26 0.27 3.59
2.67 2.69 8.02
0.77 0.001 1.54
1.26 0.27 1.80
4 0.78e3.52 0.11e1.73 1.44e5.80
1918 B.-M. Larsson et al.regarding PM10 levels, and there were also considerably
higher regarding NOx levels (5-fold) and number concen-
tration of ultrafine particles, which might explain the
different results. Furthermore, the methacholine provoca-
tion tests were performed at different time points; 7 h
after the exposure in the present study but 24 h in the
diesel exposure study. This could also account for the
discrepancies between the studies.
An additional aspect in the present study was that six of
the asthmatics on ICS had combination treatment with
long-acting beta-2-agonists. These potent bronchodilators
have been well documented to counteract bronchocon-
strictive responses and have a clear effect on bronchial
hyperresponsiveness.
Since no cellular changes in nasal lavage fluid were
observed after the road tunnel exposure, we decided to only
analyse inflammatory cytokines in a subgroup of the study
population, those who were not on a regular ICS treatment.
The results showed an increase in IL-10, IL-12p70 and TNF-
a levels, respectively. This suggests an immunostimulatory
effect due to the exposure, with activation of both pro-
inflammatory (TNF-a) as well as anti-inflammatory or TH2-
associated pathways (IL-12, IL-10).15 We only have data from
5 subjects, which limits the possibilities to analyse.
However, these markers were higher after tunnel exposure
compared to control in all cases.
In summary, we have been able to demonstrate road
tunnel exposure to give increased irritative symptoms
from the airways and bronchoconstrictive responses with
decreased PEF values in a population of mild asthmatic. In
this group of subjects with the majority on maintenance
therapy with ICS and several also using long-acting beta-2-
agonist therapy we were unable to confirm any increased
bronchial hyperresponsiveness to methacholine. In the
subgroup with steroid naive subjects, an increase in NAL
cytokine levels was demonstrated. Taken together, the
study gives additional support for asthmatics to be
a vulnerable group for traffic related air pollution.Acknowledgements
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